Ethic Inc. Has $12.24 Million Position in Danaher Corporation $DHR

Key Points

• Ethic Inc. has increased its holdings in Danaher Corporation by 8.4%, totaling 61,061 shares valued at approximately $12.24 million.
• Danaher reported a Q2 EPS of $1.80, surpassing estimates of $1.64, with revenue of $5.94 billion, reflecting a 3.4% year-over-year growth.
• The consensus rating for Danaher stock is a "Moderate Buy", with a price target averaging $247.61, highlighting substantial analyst support despite recent price adjustments.

Ethic Inc. grew its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 8.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 61,061 shares of the conglomerate's stock after acquiring an additional 4,728 shares during the quarter. Ethic Inc.'s holdings in Danaher were worth $12,236,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. GHP Investment Advisors Inc. boosted its holdings in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after acquiring an additional 99 shares during the period. Heck Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter worth about $27,000. Sierra Ocean LLC lifted its holdings in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher in the first quarter worth about $31,000. Finally, Dunhill Financial LLC lifted its holdings in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after purchasing an additional 67 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the stock. UBS Group reduced their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. HSBC cut their price target on shares of Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Guggenheim reissued a "buy" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. TD Cowen upped their price target on shares of Danaher from $240.00 to $248.00 and gave the company a "buy" rating in a report on Wednesday, April 23rd. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and an average price target of $247.61.

Danaher Trading Down 0.5%

NYSE DHR traded down $1.1050 on Wednesday, hitting $211.0950. 1,179,599 shares of the company were exchanged, compared to its average volume of 4,220,884. The company's 50 day moving average price is $200.33 and its 200-day moving average price is $199.54. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a market capitalization of $151.15 billion, a P/E ratio of 44.96, a price-to-earnings-growth ratio of 2.92 and a beta of 0.73. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.